冠状动脉造影患者动脉内注射碘对比剂后速发型与迟发型超敏反应的前瞻性研究
前瞻性观察研究纳入714例冠状动脉造影患者,动脉内使用碘佛醇或碘克沙醇,速发型超敏反应发生率3.6%、迟发型15.1%;既往动脉内碘对比剂暴露是速发型超敏反应的独立危险因素(OR 2.92),碘克沙醇较碘佛醇与更早且更频繁的迟发型超敏反应相关(OR 1.61)。
要点
- 冠状动脉造影动脉内注射碘对比剂后迟发型超敏反应(15.1%)比速发型(3.6%)更常见但严重程度更低。
- 既往动脉内碘对比剂暴露是速发型超敏反应的独立危险因素(OR 2.92,95%CI 1.22-6.96)。
- 碘克沙醇较碘佛醇与更早且更频繁的迟发型超敏反应相关(OR 1.61,95%CI 1.07-2.43)。
核心结论
- 动脉内注射碘对比剂后速发型和迟发型超敏反应发生率分别为3.6%和15.1%,既往动脉内对比剂暴露是速发型超敏反应的显著危险因素,碘克沙醇较碘佛醇与相对更早且更频繁的迟发型超敏反应相关。
研究设计与样本
- 前瞻性观察研究,纳入714例接受冠状动脉造影并使用碘佛醇(低渗非离子单体)或碘克沙醇(等渗非离子二聚体)的患者,通过造影后住院监测和出院后电话随访调查超敏反应。
诊断标准与关键数值
- 速发型超敏反应1级、2级、3级分别占57.7%、38.5%、3.8%,迟发型超敏反应1级、2级、3级分别占85.2%、13.9%、0.9%。
临床应用与阅片要点
- 冠状动脉造影使用碘对比剂时,应关注迟发型超敏反应(发生率15.1%,高于速发型3.6%);有既往动脉内碘对比剂暴露者速发型超敏反应风险更高(OR 2.92);使用碘克沙醇者迟发型超敏反应风险高于碘佛醇(OR 1.61)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: While hypersensitivity reactions (HSR) to intravenously administered iodinated contrast media (ICM) have been well studied, not much is known about HSR to intra-arterially administered ICM.
METHODS: A prospective observational study was performed to evaluate coronary angiography (CAG)-induced ICM hypersensitivity in patients who underwent CAG using ICM including ioversol, a low-osmolar non-ionic monomer, and iodixanol, an iso-osmolar non-ionic dimer. The HSR were investigated through in-patient monitoring after CAG and telephone interview after discharge.
RESULTS: A total of 714 patients were enrolled during the observation period, of whom 26 (3.6%) showed immediate HSR and 108 (15.1%) showed delayed HSR. With regard to severity, proportion of immediate HSR grades 1, 2, and 3 was 57.7%, 38.5%, and 3.8%, respectively, whereas that of delayed HSR grades 1, 2, and 3 was 85.2%, 13.9%, and 0.9%, respectively. Multivariate analysis revealed that previous intra-arterial exposure to ICM was an independent risk factor for immediate HSR (odds ratio (OR) 2.92, 95% confidence interval (CI) 1.22-6.96; p = 0.015). Iodixanol was a significant risk factor for delayed HSR (OR 1.61, 95% CI 1.07-2.43; p = 0.024) and correlated with a higher incidence of delayed HSR within 24-h post-ICM administration compared to ioversol.
CONCLUSION: The incidence rate of immediate and delayed HSR in intra-arterially administered ICM was 3.6% and 15.1%, respectively. Previous exposure to intra-arterially administered contrast media was a significant risk factor for immediate HSR. Compared to ioversol, iodixanol was associated with relatively earlier and more frequent delayed HSR.
KEY POINTS: • In this prospective study, the incidence of immediate and delayed hypersensitivity in intra-arterial injection of contrast media during coronary angiography was 3.6% and 15.1%, respectively. • Delayed hypersensitivity reactions were more common but less severe than immediate hypersensitivity reactions during coronary angiography. • Previous exposure to ICM via intra-arterial route was a significant risk factor for immediate hypersensitivity to intra-arterial contrast medium.
引用
- Sohn KH, Kim GW, Lee SY, et al. Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography. Eur Radiol. 2019. PMID: 30937592. doi:10.1007/s00330-019-06138-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。